ARTICLE | Company News

FDA approves PaxVax's Vaxchora, grants voucher

June 11, 2016 12:32 AM UTC

FDA approved a BLA for Vaxchora ( PXVX0200) from PaxVax Inc. (Redwood City, Calif.) to prevent cholera caused by serogroup O1 in adults aged 18 to 64 traveling to cholera-affected areas. PaxVax received a Priority Review voucher upon approval, as part of FDA's neglected tropical disease voucher program.

Vaxchora is the only vaccine FDA has approved to prevent cholera. ...